Aushon Biosystems Announces $7.78 Million Round A Financing.Microarrayer Now Shipping BURLINGTON, Mass. -- Aushon BioSystems, which provides microarray-based tools, instrumentation and services for life science research, drug discovery/development and clinical diagnostics, announced today that as of October 12, 2006 they had closed their Series A financing which raised $7.78 million. The Company also announced that they are now shipping their 2470 Microarrayer product to clients including the National Cancer Institute of the National Institutes of Health, the Center for Applied Proteomics and Molecular Medicine at George Mason University Named after American revolutionary, patriot and founding father George Mason, the university was founded as a branch of the University of Virginia in 1957 and became an independent institution in 1972. , and the M.D. Anderson Cancer Center in Houston, TX. The financing, which was led by North Bridge Venture Partners, with various angel investors An individual who invests his or her own money in a private company, which is typically a startup. An angel investor is not an employee or member of a bank, venture capital firm or other financial institution that normally makes such investments. also contributing, is to be used to support Aushon's current product launch and new product development. Aushon's 2470 initial microarrayer instrument was unveiled at Boston's Discovery to Diagnostics Conference in September. The 2470 can produce very high quality microarrays of a wide variety of biological materials, including those at the forefront of much current research - proteins, antibodies and cell lysates. The human genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. contains approximately 25,000 genes; the human proteome pro·te·ome n. The complete set of proteins that are produced by the genes of an organism. proteome the entire complement of proteins produced by a cell. approximately 1,000,000 protein variants. Most animals and plants of commercial interest have genomes and proteomes of comparable size. One of the keys to future discoveries in life-science, pharmacology pharmacology, study of the changes produced in living animals by chemical substances, especially the actions of drugs, substances used to treat disease. Systematic investigation of the effects of drugs based on animal experimentation and the use of isolated and and diagnostics is the ability to process genomic and proteomic assays in massively parallel See MPP. formats; both will be required to unravel the complexities of biological systems and to enable genome-based/proteome-based diagnostics and drug discovery. John Austin John Austin may refer to a:
Rich D'Amore, a Managing Partner at North Bridge and an Aushon Board Member said: "Advances in the development of multiplexed-assay and microarray See micro array. microarray - A technique for performing many DNA experiments in parallel. Nothing to do with computers. applications have great potential to speed the pace of research, in addition to opening up new options for diagnostics. We are excited to be working with Aushon BioSystems in the development of cutting-edge products in this arena." For more information on Aushon BioSystems, please visit www.aushon.com. About Aushon BioSystems Aushon BioSystems Inc. is a privately owned corporation applying advanced engineering and systems-engineering approaches to the challenges of developing life science markets. Aushon is leveraging its capabilities to develop a set of products and capabilities at the confluence confluence /con·flu·ence/ (kon´floo-ins) 1. a running together; a meeting of streams.con´fluent 2. in embryology, the flowing of cells, a component process of gastrulation. of life science and advanced engineering. Currently, Aushon BioSystems is developing the ability to produce high-quality, flexible and affordable genomic and proteomic microarray products for use in life science research, drug discovery/development, and clinical diagnostics. For more information, please visit www.aushon com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion